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Chloromethyl-triazole: A new motif for site-selective pseudo-
acylation of proteins 
Richard C. Brewster,a Georgina C. Gavins,a Barbara Günthardt,a Sarah Farr,a Kimberly M. Webb,b 
Philipp Voigtb and Alison N. Hulme*,a 
Rapid, site-selective modification of cysteine residues with 
chloromethyl-triazole derivatives generates pseudo-acyl sLys 
motifs, mimicking important post-translational modifications. 
Near-native biotinylation of peptide and protein substrates is 
shown to be site-selective and modified histone H4 retains 
functional activity.  
Advances in techniques for the site-selective functionalization 
of proteins have revolutionised approaches to investigating the 
effects of post-translational modifications (PTMs) in recent 
years.1 Cysteine is an attractive target for chemical modification 
due to its relatively low abundance in proteins and the high 
reactivity of the sulfhydryl group compared to other amino acid 
side chain functional groups which ensures good selectivity.2 
Indeed, in proteins such as histones where there are almost no 
native cysteine residues, a popular route to the systematic 
investigation of lysine modifications has been the selective 
modification of cysteine mutants to give near-native analogues 
of the parent PTM.3 This has been achieved either through the 
formation of a cleavable disulfide,4 or through S-alkylation to 
give thia-lysine derivatives (sLys),5 in which the only 
perturbation between the native lysine-containing histone and 
its cysteine-containing analogue is the switch of a CH2 for S. A 
range of amide derivatives of the side-chain of lysine are known 
as PTMs,6 with one example being the ‘native’ or endogenous 
biotinylation of proteins. The epigenetic role of biotin as a PTM 
of histones has been investigated recently.7 However, to date 
these studies have been hindered by the lack of a suitable 
reagent to chemically modify proteins with a near-native mimic 
of post-translational biotinylation, causing their conclusions to 














































Scheme 1: Routes to the formation of acyl, or pseudo-acyl sLys derivatives. 
 
 sLys derivatives mimicking the different methylation states 
of lysine have been generated through the reaction of 
methylated chloro- or bromo-ethylamines.5c Shokat et. al. have 
shown that the alkylation reaction proceeds via an intermediate 
aziridine/aziridinium, which is subsequently ring-opened by the 
nucleophilic cysteine.5c In contrast, in investigating the 
alkylation of cysteine to create acetyl lysine mimics, Cole et. al. 
have shown that alkyl halide 1a is virtually unreactive (Scheme 
1).5b Similarly, attempted ring-opening of a pre-formed acyl 
aziridine (not shown) has been shown to result in acyl transfer 
to the cysteine rather than formation of the acylated sLys 
derivative.5b An alternative strategy, employing a thiol-ene 
reaction of N-vinyl acetamide 2a has been used to generate 
acetyl lysine mimics on histones.5a However, our attempted 
synthesis of the vinyl amide of biotin 2b (either directly, or from 
bromo-ethyl derivative 1b) was unsuccessful. We were thus 
drawn to an alternative approach in which a triazole mimic of 
the amide bond would be targeted,9 and the enhanced 
reactivity of the ‘pseudo-benzylic’ halide α to the triazole would  
a. EaSTCHEM School of Chemistry, The University of Edinburgh, Joseph Black 
Building, David Brewster Road, Edinburgh EH9 3FJ, UK. 
b. The Wellcome Trust Centre for Cell Biology, The University of Edinburgh, Michael 
Swann Building, Max Born Crescent, Edinburgh, EH9 3BF, UK. 
Electronic Supplementary Information (ESI) available: Synthesis and 
characterisation of compounds 3b, 4b, and peptides Pep1-3. Peptide and protein 
alkylation procedures. See DOI: 10.1039/x0xx00000x Primary data files can be 
found at http://dx.doi.org/10.7488/ds/xxxx 
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Scheme 2: Synthesis of biotin alkylation reagent 3b. a) DPPA. TEA, tBuOH, reflux, 18 h, 
73 %; b) AcCl, EtOH, CHCl3, 4 h, 93 %; c) 8, K2CO3, CuSO4·5H2O, MeOH, 75 %; d) propargyl 
alcohol, Cu(MeCN)4BF4, DMF, 20 h, 80 %; e) SOCl2, 0.5 h, 88 %. 
give an efficient, high yielding alkylating reagent (3b, Scheme 1).  
 Synthesis of norbiotin azide 5 (Scheme 2) was achieved by a 
Curtius rearrangement of the carboxylic acid side chain on 
biotin 6,10 followed by Boc deprotection and a diazo transfer 
reaction on the amine hydrochloride 7, using imidazole-1-
sulfonyl azide hydrochloride 8.11 The CuAAC click reaction of 
azide 5 with homopropargyl bromide proceeded well under 
standard coupling conditions (65%).§ However, in reactions with 
propargyl chloride and propargyl bromide only the azide 
starting material 5 was recovered under a range of CuAAC 
conditions. Gratifyingly, the desired product (which possesses 
both the optimum length of linkage for a near-native 
connection and enhanced reactivity) could be obtained by a 
CuAAC reaction of 5 with propargyl alcohol, and subsequent 
conversion to the chloromethyl-triazole 3b using SOCl2. An 
alternative chlorination protocol,12 which employed treatment 
of the pseudo-benzylic intermediate alcohol with tosyl chloride 
gave chloromethyl-triazole 3b in reduced yields. Attempts to 
synthesise the corresponding bromide from the intermediate 
alcohol using SOBr2 were very poor yielding, and the use of 
other brominating reagents was hindered by the poor solubility 
of the intermediate triazole methyl alcohol in organic solvents.  
 To probe the selectivity and reactivity of the new 
chloromethyl-triazole reagent, a series of peptide models was 
used. Monitoring the reaction by HPLC, showed that alkylation 
of the cysteine in a short peptide sequence (Pep1: Naphthalene-
mPEG-GACR-OH) with 3b under buffered conditions was 
complete in under 6 hours [Pep1 (5.0 mM), 3b (100 mM), DTT 
(20 mM), HEPES (pH 8.0), rt]‡; no double alkylation product was 
detected by LC-MS (Figure S1). Using the same reaction 
conditions, further peptide sequences incorporating lysine and 
histidine residues (Pep2: FITC-βAla-GKAACF-NH2, Pep3: FITC-
βAla-HGKAACF-NH2) showed that alkylation by 3b was cysteine-
selective (Figure S2). The rate of alkylation of Pep1 by 
chloromethyl-triazole 3b was then compared with that of other 
methylated chloro- (9a-c), or bromo-ethylamines (10a) typically 
used to create sLys methyl lysine mimics (Figure 1).3a As 
expected, the rate of reaction was observed to increase with 
Figure 1: Relative rates of reaction of Pep1 (naphthalene-mPEG-GACR-OH) with 2-
chloroethylamine (9a, red), N-methyl 2-chloroethylamine (9b, magenta), N,N-dimethyl 
2-chloroethylamine (9c, green), 2-bromoethylamine (10a, blue), and chloromethyl-
triazole biotin (3b, black). Reactions conducted in the presence of 20 eq alkylating 
reagent, 1 M HEPES pH 8, 5 eq DTT, rt. Reactions were monitored by RP-HPLC (280 nm), 
and % conversion data represent the mean from 3 independent experiments. Error bars: 
+/- Standard Deviation.  
increasing methylation of the amine (9c > 9b > 9a),5c and the 
bromoethylamine 10a was shown to react significantly faster 
than its chloroethylamine equivalent 9a. However, 
chloromethyl triazole 3b reacts significantly faster than any of 
these reagents, with conversion levels of ~80% reached in under 
3 h. Whilst this rate of reaction is not as fast as that of a 
maleimide reagent (which is essentially instantaneous under 
equivalent conditions), it does provide a synthetically viable 
route for the selective and efficient alkylation of cysteine 
residues to give pseudo-acyl sLys derivatives. 
 Methylation of lysine residues in histones is a well-
documented epigenetic modification,13 and detailed protocols 
for the synthesis of near-native sLys analogues from the 
corresponding KxxC mutant histones have been published.5 
Biotinylation of histone H4 (H4K12bio14 and H4K16bio15) has 
also been proposed to play an epigenetic role; with H4K16bio 
shown to affect chromatin condensation levels in studies 
conducted using non-native maleimide-PEG2-biotin reagents. 
Gratifyingly, treatment of the histone 4 mutant H4K12C with 
chloromethyl triazole 3b, under standard histone alkylation 
conditions [Protein (0.9 mM), 3b (90 mM), DTT (20 mM), HEPES 
(pH 7.8), guanidine (4 M), rt]16 proceeded to completion in only 
4 h. Purification using a size exclusion spin cartridge to desalt 
and remove excess alkylating reagent, and mass spectrometric 
analysis showed only the sLys biotin alkylated histone 
accompanied by very low levels of a double alkylation product 
(Figure 2a). We have previously demonstrated that a range of 
non-hydrolysable triazole derivatives of biotin show very strong 
binding to avidin, with Kd values in the pM range.17 In this 
instance, functional activity of the H4K12C triazole biotin adduct 
was demonstrated by Western blot using an anti-biotin 
antibody (Figure 2b), and the assembly of histone complexes 
incorporating site-selective biotinylation is currently under 
investigation. 
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Figure 2: (a) Mass spectrometric analysis of the product of reaction of H4K12C with 
chloromethyl-triazole biotin reagent 3b. (b) Western blot of the sLys biotin derivative of 
H4K12C using anti-biotin (Bethyl).  
 In summary, we have demonstrated that a chloromethyl-
triazole motif can be used to introduce site selective, near-
native mimics of amide-based PTMs into peptide and protein 
substrates. Using biotin chloromethyl-triazole 3b as an 
example, the rate of cysteine alkylation was shown to be faster 
than that of commonly used (methyl)amino ethyl-halides; and 
functional activity of the resultant pseudo-acyl derivatives was 
confirmed by Western blot with anti-biotin. Due to the wide 
range of easily accessible functional azides and simple 
conversion to the corresponding chloromethyl-triazole, this 
motif could serve as a robust method for the rapid installation 
of PTM acetylation mimics into proteins. This chemical 
derivatisation approach complements acetylation techniques 
which rely on the genetic introduction of unnatural amino 
acids,18 which can be hampered by low protein expression 
levels. Ongoing efforts in our laboratories seek to expand this 
strategy to sugars, phosphates and fatty acids, and to exploit 
the high reactivity observed for chloromethyl-triazole based 
reagents in dual labelling studies.   
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